Upstream Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.70

+0.31 (+9.14%)

As of Nov 7, 1:49 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 3 25%

Sell 0 0%

Price Target

Analyst Price Target +567.0% upside

Low Target $18.50

Average Target $24.68

High Target $35.72

Current Price $3.70

Current
$3.70

Target
$24.68

$18.50 $24.68 avg $35.72

Scenario Analysis

Bear Case

$18.50

400.0%

Low target

Base Case

$24.68

+567.0%

Avg target

Bull Case

$35.72

+865.4%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$33.68

-89.0% from high

52-Week Low

$2.68

+38.1% from low

Target vs 52W High

$24.68

-26.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-11.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+117.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.9%
MRNA Moderna Inc	Hold	31	35%	$149.45	-41.2%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-54.0%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-40.7%